Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × enzalutamide × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 42 Prostatic Neoplasms, Castration-Resistant 5 Neoplasms 4 Neoplasm Metastasis 4 Metastatic Castration-Resistant Prostate Cancer 3 Small Cell Lung Carcinoma 2 Recurrence 2 Metastatic Hormone-sensitive Prostate Cancer 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Cancer 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Primary Dysautonomias 1 Pathologic Complete Response 1 PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy 1 Neoplasm, Residual 1 Metastatic Hormone Sensitive Prostate Cancer 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Lymphoma, Follicular 1 Kidney Diseases 1 Hypertension 1 Dementia 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Carcinoma, Small Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

Cisplatin 11 pembrolizumab 8 Paclitaxel 7 Drug Therapy 6 Irinotecan 4 Fluorouracil 4 Carboplatin 4 toripalimab 3 Radiotherapy 3 tislelizumab 2 nimotuzumab 2 Oxaliplatin 2 Nivolumab 2 Levoleucovorin 2 Leucovorin 2 Docetaxel 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 regorafenib 1 osimertinib 1 nedaplatin 1 lenvatinib 1 futibatinib 1 durvalumab 1 camrelizumab 1 atezolizumab 1 aflibercept 1 Tiragolumab 1 Surgical Procedures, Operative 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡